Jennifer Fortune

Jen Fortune joined Flagship Pioneering in 2021 and is a senior operating principal on the venture creation team led by Geoff Von Maltzahn. In this role, she partners with a team of entrepreneurial scientists to found and successfully operationalize and grow companies that transform the way we think about and develop therapeutics.

Jen joined Flagship Pioneering from EMD Serono where she established the North American Launch Office to successfully deliver four U.S. product launches over two years across Oncology and Immunology indications. She also served as Head of Office for the President of North America and Head of the Innovative Medicines Commercial Franchises, leading all operational activities for both functional units. Prior to joining EMD Serono, Jen was with the Boston Consulting Group for over eight years, leading more than 30 strategic and operational projects for leading Healthcare players, including helping to establish a Public Private Partnership between the NIH, academics, and global pharmaceutical players.

Jen has a keen interest in Diversity, Equality, and Inclusion topics. In addition to her functional responsibilities, Jen has partnered with company leadership in each of her roles to establish robust programs to evolve ways of working to better support and enable diverse teams.

Jen received her Ph.D. at MIT in Biological Chemistry in the lab of Dr. Alexander Klibanov, focusing on non-viral nucleic acid delivery for therapeutic purposes.